Acoramidis for the Treatment of Transthyretin Cardiac Amyloidosis

By afschroeder • October 31, 2025

Pillai AA, Mogga B, Passey S, Frishman WH, Aronow WS. Acoramidis for the Treatment of Transthyretin Cardiac Amyloidosis. Cardiol Rev. 2025 Oct 20. doi: 10.1097/CRD.0000000000001074. Epub ahead of print. PMID: 41166689.

Tags: acoramidis, cardiac amyloidosis, Cardiology/Epi, Harbor UCLA, heart failure, Publications, transthyretin stabilizer

SPIROMICS HF: Rationale, Design, and Reproducibility of Measures

Barr RG, Lima JAC, Prince MR, Ambale Venkatesh B, Abraham T, Agarwal PP, Arora G, Balasubramanian A, Barjaktarevic I, Bello NA, Bluemke DA, Budoff MJ,[...]

Atrial Fibrillation and Cancer: Bidirectional Relationship and Potential for Personalized Care

Grewal US, Byer SH, Mahajan S, Sheth AR, Beedupalli K, Fradley MG, Yang EH, Russo AM, Asnani A, Dominic P. Atrial Fibrillation and Cancer: Bidirectional[...]

Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes from the STORM-PE Trial

Lookstein RA, Konstantinides SV, Weinberg I, Dohad SY, Rosol Z, Kopeć G, Moriarty JM, Parikh SA, Holden A, Channick RN, McDonald B, Nagarsheth KH, Yamada[...]